Cargando…
Crystal structure of the catalytic domain of botulinum neurotoxin subtype A3
Botulinum neurotoxins (BoNTs) are among the most widely used therapeutic proteins; however, only two subtypes within the seven serotypes, BoNT/A1 and BoNT/B1, are currently used for medical and cosmetic applications. Distinct catalytic properties, substrate specificities, and duration of enzymatic a...
Autores principales: | Leka, Oneda, Wu, Yufan, Li, Xiaodan, Kammerer, Richard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135040/ https://www.ncbi.nlm.nih.gov/pubmed/33891946 http://dx.doi.org/10.1016/j.jbc.2021.100684 |
Ejemplares similares
-
A Novel Inhibitor Prevents the Peripheral Neuroparalysis of Botulinum Neurotoxins
por: Azarnia Tehran, Domenico, et al.
Publicado: (2015) -
High‐resolution crystal structures of the botulinum neurotoxin binding domains from subtypes A5 and A6
por: Davies, Jonathan R., et al.
Publicado: (2020) -
Crystal Structure of the Catalytic Domain of a Botulinum Neurotoxin Homologue from Enterococcus faecium: Potential Insights into Substrate Recognition
por: Gregory, Kyle S., et al.
Publicado: (2023) -
Crystal Structures of Botulinum Neurotoxin Subtypes A4 and A5 Cell Binding Domains in Complex with Receptor Ganglioside
por: Gregory, Kyle S., et al.
Publicado: (2022) -
Structural Features of Clostridium botulinum Neurotoxin Subtype A2 Cell Binding Domain
por: Gregory, Kyle S., et al.
Publicado: (2022)